Interview, Fireside Chat, Conference Presentation
Consolidation in Healthcare: What to Make of It?
- Walmart is in the early stages of potentially acquiring Humana.
- Walmart and CVS are positioned to drive greater value through local operations, direct patient ownership, and control of touch points.
- The Berkshire Hathaway, Amazon, and JP Morgan consortium is expected to have a limited impact due to geographic dispersion and the inability to place all employees within a single local hospital.
- Amazon is projected to build an internal Pharmacy Benefit Manager (PBM) rather than acquire an existing one to navigate opaque margins and maximize disruption potential.
- Amazon's strategy may prioritize utilizing current partnerships to learn the sector and hire talent over acquiring a marquee property in the space.
- While an acquisition of CVS and Aetna by Amazon is considered unlikely, such a move remains a possibility if Bezos decides to surprise the market.
- A new "digital PBM logistics chain" is anticipated to emerge to manage the complexities of cell therapies and gene therapies.
- The timeline for a new business model for cell therapies is expected to arrive sooner than for other advanced medicines, driven by high current costs and immediate spending.